Twenty-eight states mandate some form of insurance coverage for off-label pharmaceutical use, and the trend is accelerating. In 1997, 11 states implemented off-label coverage provisions. Such laws typically forbid coverage denials based on grounds that an indication has not been approved by the Food and Drug Administration.
SOURCE: STATELINE, SCOTT-LEVIN GOVERNMENT AFFAIRS, NEWTOWN, PA., 1998
More like this
- Terms of California Reform Debate Clearer as Sides Develop Want Lists
- Doctors: FDA Threatens Strategy To Manage High-Risk Pregnancies
- DTC Ads Hit Mark, Drive Increases In Office Visits
- More cost-shifting in the pharmacy benefit: Copayments at new highs, while 3-tier formularies spread
- Off-Label Use Often Presents Conundrum for Health Plans
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.